Title of article
Exosomal tumor-suppressive microRNAs as novel cancer therapy: “Exocure” is another choice for cancer treatment
Author/Authors
Kosaka، نويسنده , , Nobuyoshi and Takeshita، نويسنده , , Fumitaka and Yoshioka، نويسنده , , Yusuke and Hagiwara، نويسنده , , Keitaro and Katsuda، نويسنده , , Takeshi and Ono، نويسنده , , Makiko and Ochiya، نويسنده , , Takahiro، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2013
Pages
7
From page
376
To page
382
Abstract
MicroRNAs (miRNAs) act to fine-tune cellular responses in a variety of biological circumstances such as development, organogenesis, and homeostasis. The dysregulation of miRNA expression accelerates disease progression, including metabolic disease, immunological disease and cancer, through the gene network disorder. Therefore, understanding the miRNA maturation process may unravel the mechanisms of cancer malignancy; however, the life of miRNA has not been clarified. In this article, we summarize the recent findings regarding the novel forms of miRNA, especially secretory miRNAs, focusing on exosomal miRNAs. Recent research has revealed that exosomal miRNAs affect many aspects of physiological and pathological conditions, and may be useful as novel therapy. Here, we propose a method for the delivery of tumor-suppressive miRNAs to desired sites using exosomes, and we named this method “exocure”.
Keywords
Cell–cell communication , Tumor initiation , Exosomes , Drug delivery system , Exosome , microvesicle , Tumor-suppressive microRNA , Secretory microRNAs , Small RNA therapy
Journal title
Advanced Drug Delivery Reviews
Serial Year
2013
Journal title
Advanced Drug Delivery Reviews
Record number
1763664
Link To Document